Canadian Nursery Big League Genetics Exports Cannabis Strains To German Producer DEMECAN

In a landmark move for the cannabis industry, Big League Genetics, a prominent Canadian cannabis nursery, has successfully completed its first export of cannabis genetics to DEMECAN, a licensed producer in Germany. This collaboration not only marks a significant milestone for both companies but also aligns with the recent legislative changes in Germany, where recreational cannabis has been legalized.

Dave Auger, Commissioner of Big League Genetics, expressed enthusiasm about the partnership, highlighting the company's ongoing commitment to supplying DEMECAN with medical cannabis and now extending their collaboration to include genetics. This step is seen as a pivotal moment for Big League as it continues to expand its footprint in European markets.

Dr. Adrian Fischer, Managing Director and Co-Founder of DEMECAN, views this partnership as an opportunity to enhance the German and European markets with superior cannabis genetics. Leveraging their tissue culture lab, DEMECAN aims to set new benchmarks for quality and innovation in the sector.

Both Big League Genetics and DEMECAN, along with their partner 3WIN Corp, will be participating in The International Cannabis Business Conference scheduled for April 16-17 in Berlin. This event will provide a platform for the companies to showcase their latest offerings and discuss the future of cannabis genetics and cultivation.

Since 2021, Big League Genetics has been at the forefront of providing high-quality cannabis genetics to licensed producers across Canada. With a focus on discovering new commercial cannabis cultivars and supplying dried cannabis flower to regulated medical markets globally, Big League boasts an extensive seed collection and a selection of proven commercial cannabis genetics for licensed jurisdictions.

About DEMECAN

DEMECAN stands as the only independent German company that manages the entire value chain for medical cannabis - from cultivation and processing to storage and distribution to pharmacies. Founded in 2017 by Drs. Adrian Fischer, Cornelius Maurer, and Constantin von der Groeben, DEMECAN aims to ensure patient access to high-quality medical cannabis made in Germany. In 2019, it was awarded a state contract by the Federal Institute for Drugs and Medical Devices to cultivate medical cannabis in Germany, underscoring its commitment to excellence.

About 3WIN Corp

3WIN Corp is a leading global wholesale distributor of top-tier CCELL® vape products catering to the cannabis and hemp industry. As the preferred distributor of CCELL® products, 3WIN is dedicated to maintaining product integrity, ensuring safe user experiences, and enhancing brand identity through high-quality offerings and customized packaging solutions.

This strategic partnership between Big League Genetics and DEMECAN signifies a new era in the international cannabis market, promising advancements in cannabis genetics and cultivation practices that could redefine industry standards globally.